A randomized, two period, double-blind placebo-controlled and open label, multicenter extension study to determine the long-term safety and tolerbility of JNJ-54861911 in subjects in the early Alzheimer's Disease Spectrum

Identifizierung von funktionellen Biomarkern für Tinnitus und Hyperakusis im Tiermodell und Menschen

A Multicenter, Follow-up Study to Assess Long-Term Electrophysiologic and Clinical Outcomes in Subjects Previously Enrolled in Study 215ON201

BMS CA209-498 – A Randomized Phase 3 Open Label Study of Nivolumab vs Temozolomide Each in Combination with Radiation Therapy in Newly Diagnosed Adult Subjects with Unmethylated MGMT (tumor O-6-methylguanine DNA methyltransferase) Glioblastoma

A Phase Ib/II, open-label, multicenter study of INC280 in combination with buparlisib in adult patients with recurrent glioblastoma

ABT-414 alone or ABT-414 plus temozolomide versus lomustine or temozolomide for recurrent glioblastoma: a randomized phase II study of the EORTC Brain Tumor Group